Epidemiology of the delta globin alleles in southern Italy shows complex molecular, genetic, and phenotypic features

Human Mutation

Volumn 20, Issue 5, 2002, Pages 358-367

  De Angioletti, Maria ^a   Lacerra, Giuseppina ^a   Gaudiano, Carlo ^b   Mastrolonardo, Gabriella ^a   Pagano, Leonilde ^c   Mastrullo, Lucia ^d   Masciandaro, Santa ^b   Carestia, Clementina ^a  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b ASL   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

^d Ospedale San Giovanni Bosco   (Italy)

Author keywords

Beta thalassemia prevention; Delta globin; Delta thalassemia; Gene modifiers; Genotype phenotype; HBD; Mutation detection

Indexed keywords

DELTA GLOBIN; HEMOGLOBIN A2;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSING OVER; GENE DELETION; GENE MUTATION; GENETIC CODE; GENETIC COUNSELING; GENETIC EPIDEMIOLOGY; GENETIC SCREENING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HETEROZYGOTE; HUMAN; ITALY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN MOTIF; RNA SPLICING; THALASSEMIA;

ALLELES; BASE SEQUENCE; GENOTYPE; GLOBINS; HAPLOTYPES; HEMOGLOBINS; HETEROZYGOTE; HUMANS; ITALY; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; THALASSEMIA;

LUCANIA;

EID: 0036409980     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.10132     Document Type: Article

References (43)

1. Aksoy M, Erdem S. 1966. Hemoglobin A′2 abnormality associated with thalassemia minor in a Greek woman. Study of a family. Isr J Med Sci 2:310-313.
2. Antonarakis SE, Boehm CD, Serjeant GR, Theisen CE, Dover GJ, Kazazian HH Jr. 1984.Origin of the beta S-globin gene in blacks: The contribution of recurrent mutation or gene conversion or both. Proc Natl Acad Sci USA 81:853-856.
3. Antonarakis SE, Nomenclature Working Group. 1998. Recommendations for a nomenclature system for human gene mutations. Hum Mutat 11:1-3.
4. Bento MC, Ribeiro ML, Cunha E, Rebelo U, Granjo E, Granado C, Tamagnini GP 2000. Hb Vila Real [β36(C2)Pro>His]: A newly discovered high oxygen affinity variant. Hemoglobin 24:59-63.
5. 2. Clin Chim Acta 55:49-55.
6. Bowden DK, Vickers MA, Higgs DR. 1992. A PCR-based strategy to detect the common severe determinants of α thalassaemia. Br J Haematol 81:104-108.
7. thal chromosomes and its usefulness in prenatal diagnosis. Br J Haematol 67:231-234.
8. -2- NYU in a London population. Hum Hered 25:13-17.
9. Chakravarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, Kazazian HH. 1984. Nonuniform recombination within the human β-globin gene cluster. Am J Hum Genet 36:1239-1258.
10. anti-3.7 type II: A new α-globin gene rearrangement suggesting that the α-globin gene duplication could be caused by intrachromosomal recombination. Hum Genet 89:37-41.
11. 2-NYU in the Netherlands. Incidence of δ-chain variants in human populations. Hum Hered 24:32-39.
12. anti 3.7 triplication by enzymatic amplification analysis. Br J Haematol 83:105-111.
13. Drakoulakou O, Papapanagiotou E, Loutradi-Anagnostou A, Papadakis M. 1997. δ-thalassemic phenotype due to two "novel" δ-globin gene mutations: (CD11 GTC>GGC(A8)-HbA2-Pylos) and (CD85 TTT>TCT(F1)-HbA2-Etolia). Hum Mutat 9:344-347.
14. Eliakim R, Rachmilewitz EA. 1983. Hemoglobinopathies in Israel. Hemoglobin 7:479-485.
15. Fullerton SM, Clegg JB. 1994. HpaI, HindIII, and BamHI polymorphisms 3′ of the human β-globin gene can bedetected by a single polymerase chain reaction amplification product. Am J Hematol 47:256.
16. Galanello R, Melis MA, Podda A, Monne M, Perseu L, Loudianos G, Cao A, Pirastu M, Piga A. 1990. Deletion δ-thalassemia: The 7.2 kb deletion of Corfu δβ-thalassemia in a non-β-thalassemia chromosome. Blood 75:1747-1749.
17. Giardina B, Brunori M, Antonini E, Tentori L. 1978. Properties of hemoglobin G. Ferrara [β57(E1) Asn>Lys]. Biochim Biophys Acta 534:1-6.
18. +27-thalassaemia in Sardinians. Clin Lab Haematol 18:241-244.
19. Huisman TH, Jonxis JH. 1977. The Hemoglobinopathies Techniques of Identification. New York: Marcel Dekker, Inc. p 105-110.
20. Huisman TH, Carver MF. 1998. The β- and δ-thalassemia repository. 9th ed., part I. Hemoglobin 22:169-195.
21. Jiang NH, Liang S, Su C, Nechtman JF, Stoming, TA. 1993. A novel β-thalassemia mutation IVS-II-5 (G>C) in a Chinese family from Guangxi Province, P.R. China. Hemoglobin 17:563-567.
22. Kulozik AE, Lyons J, Kohne E, Bartram CR, Kleihauer E. 1988. Rapid and non-radioactive prenatal diagnosis of β thalassaemia and sickle cell disease: Application of the polymerase chain reaction PCR. Br J Haematol 70:455-458.
23. Li HW, Codrington JF, Schilir ÚG, Wadsworth LD, Beris P, Adekile A, Huisman TH. 1991. The usefulness of sequence analysis of amplified DNA for the identification of 6 chain variants. Hemoglobin 15:77-84.
24. Matsuda M, Sakamoto N, Fukumaki Y. 1992. 6-Thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the 6-globin gene promoter. Blood 80:1347-1351.
25. 2 β-thalassemia. Blood 72:530-533.
26. 0-thalassemia functions normally on transient expression in heterologous cells. Blood 70:809-813.
27. Old JM, Varawalla NY, Weatherall DJ. 1990. Rapid detection and prenatal diagnosis of β-thalassaemia: Studies in Indian and Cypriot populations in the UK. Lancet 336:834-837.
28. 2 levels. Hemoglobin 24:195-201.
29. Orkin SH, Kazazian HH, Antonarakis SE, Goff SC, Boehm CD, Sexton JP, Waber PG, Giardina PJ. 1982. Linkage of β-thalassaemia mutations and β-globin gene polymorphisms with DNA polymorphisms in human β-globin gene cluster. Nature 296:627-631.
30. Pagano L, Lacerra G, Camardella L, De Angioletti M, Fioretti G, Maglione G, de Bonis C, Guarino E, Viola A, Cutolo R, De Rosa L, Carestia C. 1991. Hemoglobin Neapolis, [β126(H4)Val>Gly]: A novel β-chain variant associated with a mild β-thalassemia phenotype and displaying anomalous stability features. Blood 78:3070-3075.
31. 2-Agrinio [δ43(CD2)Glu>Gly(GAG>GGG)]: A new × chain variant detected in a Greek family. Hemoglobin 19:295-299.
32. Paviou E, Kyrri A, Makariou C, Kalogerou E, Vasiliades P, Kleanthous M. 2001. The prevalence of δ-thalassemia in Cyprus. In: The 8th International Conference on Thalassemia and the Hemoglobinophaties, Athens, Greece. p 211.
33. +-thalassemia in Sardinia. Blood 62:341-345.
34. 2 12lys. J Clin Invest 48:2057-2062.
35. Ribeiro ML, Gu LH, Buchanan-Adair I, Huisman TH. 1993. Incorrect genetic counseling of a couple with β-thalassemia, due to incomplete testing. Am J Hum Genet 52:842-843.
36. Schilliro G, Russo-Mancuso G, Dibenedetto SP, Samperi P, di Cataldo A, Ragusa R, Testa R. 1991. Six rare hemoglobin variants found in Sicily. Hemoglobin 15:431-437.
37. [116Arg>His(G18)]. Biochim Biophys Acta 393:379-382.
38. Trifillis P, Kyrri A, Kalogirou E, Kokkofitou A, Ioannou P, Schwartz E, Surrey S. 1993. Analysis of δ-globin gene mutations in Greek Cypriots. Blood 82:1647-1651.
39. Tzetis M, Traeger-Synodinos J, Kanavakis E, Metaxotou-Mavromati A, Kattamis C. 1994. The molecular basis of normal HbA2 type 2 β-thalassemia in Greece. Hematol Pathol 8:25-34.
40. 2-NYU in Canada. Can J Biochem 50:841-843.
41. 2 Hemoglobin 1:619-650.
42. Vullo C, Cristofori G, Salsini G, Tentori L, Marinucci M, Bruni E. 1974. Haemoglobin G Ferrara: A new amino acid substitution. Internal Research Communication System 2:1553.
43. Wilkinson T, Chua CG, Carrell RW, Robin H, Exner T, Lee KM, Kronenberg H. 1975. Haemoglobin Camperdown [β104 (G6) arginine → serine]. Biochim Biophys Acta 393:195-200.